Genscript appears attractive - not just Legend's product pipeline and strong partnerships; but also Genscript's stub ops have been performing well. I wouldn't long/short this. Perhaps an outright long
What is covered in the Full Insight:
Bullish and Bearish Points
Conclusions First
Legend Biotech and Carvykti
Mergers and Acquisitions Process
Genscript and Legend's Financial Performance
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.